These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1560440)
21. 3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists. Nordvall G; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U J Med Chem; 1996 Aug; 39(17):3269-77. PubMed ID: 8765510 [TBL] [Abstract][Full Text] [Related]
22. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes. Messer WS; Ellerbrock B; Price M; Hoss W Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779 [TBL] [Abstract][Full Text] [Related]
23. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Ward TR; Ferris DJ; Tilson HA; Mundy WR Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012 [TBL] [Abstract][Full Text] [Related]
24. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR; Wolfe BB Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [TBL] [Abstract][Full Text] [Related]
26. Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist. Wang H; Cui WY; Liu CH Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):497-9. PubMed ID: 9863140 [TBL] [Abstract][Full Text] [Related]
27. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors. Daly JW; Gupta TH; Padgett WL; Pei XF J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110 [TBL] [Abstract][Full Text] [Related]
28. Muscarinic receptor binding and activation of second messengers by substituted N-methyl-N-[4-(1-azacycloalkyl)-2-butynyl]acetamides. Bradbury BJ; Baumgold J; Paek R; Kammula U; Zimmet J; Jacobson KA J Med Chem; 1991 Mar; 34(3):1073-9. PubMed ID: 1848294 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors. Street LJ; Baker R; Book T; Kneen CO; MacLeod AM; Merchant KJ; Showell GA; Saunders J; Herbert RH; Freedman SB J Med Chem; 1990 Oct; 33(10):2690-7. PubMed ID: 2213823 [TBL] [Abstract][Full Text] [Related]
30. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport. Zimmerman TW; Binder HJ Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277 [TBL] [Abstract][Full Text] [Related]
31. Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex. Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM Br J Pharmacol; 1985 Jul; 85(3):697-703. PubMed ID: 4027484 [TBL] [Abstract][Full Text] [Related]
32. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue. Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989 [TBL] [Abstract][Full Text] [Related]
33. Resolved pyrrolidine, piperidine, and perhydroazepine analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Lundkvist JR; Vargas HM; Caldirola P; Ringdahl B; Hacksell U J Med Chem; 1990 Dec; 33(12):3182-9. PubMed ID: 2258904 [TBL] [Abstract][Full Text] [Related]
34. Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brain. Messer WS; Ngur DO; Abuh YF; Dokas LA; Ting SM; Hacksell U; Nilsson BM; Dunbar PG; Hoss W Chirality; 1992; 4(8):463-8. PubMed ID: 1476855 [TBL] [Abstract][Full Text] [Related]
35. Beta-lactam analogues of oxotremorine. 3- and 4-methyl-substituted 2-azetidinones. Nilsson BM; Ringdahl B; Hacksell U J Med Chem; 1990 Feb; 33(2):580-4. PubMed ID: 2299626 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological profiles of an anticholinergic agent, phencynonate hydrochloride, and its optical isomers. Wang LY; Wang Y; Zheng JQ; Zhong BH; Liu H; Dong SJ; Ruan JX; Liu KL Acta Pharmacol Sin; 2005 May; 26(5):527-32. PubMed ID: 15842768 [TBL] [Abstract][Full Text] [Related]
37. Cholinergic agents: effect of methyl substitution in a series of arecoline derivatives on binding to muscarinic acetylcholine receptors. Moos WH; Bergmeier SC; Coughenour LL; Davis RE; Hershenson FM; Kester JA; McKee JS; Marriott JG; Schwarz RD; Tecle H J Pharm Sci; 1992 Oct; 81(10):1015-9. PubMed ID: 1432612 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity. Suzuki T; Uesaka H; Hamajima H; Ikami T Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):876-9. PubMed ID: 10399839 [TBL] [Abstract][Full Text] [Related]
39. The binding of agonists to brain muscarinic receptors. Birdsall NJ; Burgen AS; Hulme EC Mol Pharmacol; 1978 Sep; 14(5):723-36. PubMed ID: 714021 [No Abstract] [Full Text] [Related]
40. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes. el-Fakahany EE; Ramkumar V; Lai WS J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]